Israel isolates coronavirus antibody in ‘significant breakthrough’: minster
The Israel Institute for Biological Research (IIBR) has developed an antibody or inactivated vaccine that can attack and neutralize viruses responsible for COVID-19 within the bodies of infected people.
JERUSALEM: Israel has isolated a significant coronavirus antibody at its main biological research laboratory, Israel isolates coronavirus antibody the Israeli Defense Minister said on Monday, calling the move a “significant breakthrough” toward a possible treatment for the coronavirus epidemic.
“Monoclonal neutralizing antibodies developed for the Israel Institute for Biological Research (IIBR)” may neutralize it (the disease-causing coronavirus), “Defense Minister Naftley Bennett said in a statement.
Israel isolates coronavirus antibody The statement said Bennett visited the Israel Institute for Biological Research on Monday where he was briefed on “significant success in finding an antidote for coronavirus”.
It quoted IIBR director Shmuel Shapira that the antibody formula was being patented, after which an international manufacturer would be sought to produce it.
IIBR is spearheading Israel’s efforts to develop a treatment and vaccine for coronavirus, including blood screening from COVID-19, a respiratory disease caused by the virus.
Antibodies in such samples – immune-system proteins that are the residues of successfully overcoming coronaviruses – Israel develops coronavirus antibody are widely seen as the key to developing a potential cure.
The antibody isolated in IIBR is called monoclonal, Israel isolates coronavirus antibody meaning that it was derived from a recovered cell and thus has the potential for a more potent value in a treatment yield.
The journal Science Direct reported in its May issue that elsewhere COVID-19 therapies were developed with antibodies Israel develops coronavirus antibody that is polyclonal or derived from two or more cells of different lineages.
Israel was one of the first countries to impose increasingly stringent restrictions on the movement to close its borders and disrupt the domestic Covid-19 outbreak. There were 16,246 cases and 235 deaths due to the disease.